Experts say patients can get results before they leave the doctor’s office, allowing them to start treatments earlier. Share on Pinterest Researchers say the new chlamydia test is just as accurate as ...
When, a handful of years ago, the U.S. and Canada changed their screening guidelines for cervical cancer, it was an acknowledgment that screenings for young women carried unintended harms. However, a ...
Background: Screening programmes are promoted to control transmission of and prevent female reproductive tract morbidity caused by genital chlamydia. The objective of this study was to examine the ...
The value of opportunistic chlamydia screening is being called into question. An epidemiologist at the University of Berne in Switzerland argues that claims about screening are not supported by ...
Most new Chlamydia trachomatis (CT) infections in the United States occur among individuals aged 15 to 24 years, yet traditional risk-based screening often fails to capture asymptomatic cases.
Sept. 14 (UPI) --All sexually active women and pregnant people age 24 years and younger should be screened for chlamydia and gonorrhea, according to new guidelines published Tuesday by JAMA. In ...
Please provide your email address to receive an email when new articles are posted on . A novel community-based chlamydia screening program meant to reach young Black men in New Orleans proved to be ...
It is unlikely that single screening for chlamydia will prevent women developing pelvic inflammatory disease in the following year, according to new research. It is unlikely that single screening for ...
The main thing to know about chlamydia symptoms is that most people don’t notice any. The fact that chlamydia is a so-called silent illness is one big reason that the disease has become so common. It ...
A 2012 cervical cancer screening guideline change is associated with reduced testing for cervical cancer and chlamydia and reduced identification of chlamydia cases in young women. Screening for ...
Our systematic review assessed evidence for the effectiveness of chlamydia screening in preventing chlamydia-associated morbidity or transmission of infection. Trial reporting quality was generally ...